Annual Accounts Receivable
$2.55 M
+$640.20 K+33.48%
December 31, 2023
Summary
- As of March 10, 2025, SBFM annual accounts receivable is $2.55 million, with the most recent change of +$640.20 thousand (+33.48%) on December 31, 2023.
- During the last 3 years, SBFM annual accounts receivable has risen by +$2.55 million (+134236.84%).
- SBFM annual accounts receivable is now -99.99% below its all-time high of $28.97 billion, reached on December 1, 2003.
Performance
SBFM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$3.22 M
-$754.80 K-19.00%
September 30, 2024
Summary
- As of March 10, 2025, SBFM quarterly accounts receivable is $3.22 million, with the most recent change of -$754.80 thousand (-19.00%) on September 30, 2024.
- Over the past year, SBFM quarterly accounts receivable has stayed the same.
- SBFM quarterly accounts receivable is now -19.00% below its all-time high of $3.97 million, reached on June 30, 2024.
Performance
SBFM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SBFM Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | 0.0% |
| 3 y3 years | +10000.0% | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
SBFM Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -19.0% | -100.0% |
| 5 y | 5-year | at high | >+9999.0% | -19.0% | -100.0% |
| alltime | all time | -100.0% | -100.0% | -19.0% | -100.0% |
Sunshine Biopharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.22 M(-19.0%) |
| Jun 2024 | - | $3.97 M(+40.5%) |
| Mar 2024 | - | $2.83 M(+10.8%) |
| Dec 2023 | $2.55 M(+33.5%) | $2.55 M(+25.5%) |
| Sep 2023 | - | $2.03 M(+1.1%) |
| Jun 2023 | - | $2.01 M(+12.3%) |
| Mar 2023 | - | $1.79 M(-6.4%) |
| Dec 2022 | $1.91 M(>+9900.0%) | $1.91 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $7800.00(+310.5%) | - |
| Dec 2021 | - | $7800.00(+609.1%) |
| Sep 2021 | - | $1100.00(>+9900.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $1900.00 | $1900.00(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $400.00(>+9900.0%) | $400.00(-60.0%) |
| Jun 2019 | - | $1000.00(-99.2%) |
| Mar 2019 | - | $119.20 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $102.90 K(-4.9%) |
| Jun 2018 | - | $108.20 K(+17.1%) |
| Mar 2018 | - | $92.40 K(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $1000.00(>+9900.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $103.20 K(+5331.6%) |
| Jun 2015 | - | $1900.00 |
| Dec 2003 | $28.97 B(+0.7%) | - |
| Dec 2002 | $28.76 B(+64.7%) | - |
| Dec 2001 | $17.47 B(-34.4%) | - |
| Dec 2000 | $26.61 B(+43.0%) | - |
| Dec 1999 | $18.60 B(+34.0%) | - |
| Dec 1998 | $13.89 B | - |
FAQ
- What is Sunshine Biopharma annual accounts receivable?
- What is the all time high annual accounts receivable for Sunshine Biopharma?
- What is Sunshine Biopharma annual accounts receivable year-on-year change?
- What is Sunshine Biopharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly accounts receivable year-on-year change?
What is Sunshine Biopharma annual accounts receivable?
The current annual accounts receivable of SBFM is $2.55 M
What is the all time high annual accounts receivable for Sunshine Biopharma?
Sunshine Biopharma all-time high annual accounts receivable is $28.97 B
What is Sunshine Biopharma annual accounts receivable year-on-year change?
Over the past year, SBFM annual accounts receivable has changed by +$640.20 K (+33.48%)
What is Sunshine Biopharma quarterly accounts receivable?
The current quarterly accounts receivable of SBFM is $3.22 M
What is the all time high quarterly accounts receivable for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly accounts receivable is $3.97 M
What is Sunshine Biopharma quarterly accounts receivable year-on-year change?
Over the past year, SBFM quarterly accounts receivable has changed by $0.00 (0.00%)